Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction

Arthritis and Rheumatism

Volumn 46, Issue 1, 2002, Pages 149-162

  Kaps, Christian ^a,b   Bramlage, Carsten ^a   Smolian, Heike ^b   Haisch, Andreas ^a   Ungethüm, Ute ^a   Burmester, Gerd R ^a   Sittinger, Michael ^a   Gross, Gerhard ^c   Häupl, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TRANSTISSUE TECHNOLOGIES GMBH   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; COMPLEMENTARY DNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; FIBROBLAST; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TRANSGENE;

EID: 0036164197     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200201)46:1<149::AID-ART10058>3.0.CO;2-W     Document Type: Article

References (56)

1. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction?
2. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
3. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts
4. Cytokines in rheumatoid arthritis
5. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
6. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes
7. Defining therapeutic targets by using adenovirus: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
8. Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model
9. Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation
10. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects
11. Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects
12. Synthesis of articular cartilage-like tissue in vitro
13. Beneficial effect of basic fibroblast growth factor on the repair of full-thickness defects in rabbit articular cartilage
14. Hepatocyte growth factor facilitates cartilage repair: Full thickness articular cartilage defect studied in rabbit knees
15. Repair of partial-thickness defects in articular cartilage: Cell recruitment from the synovial membrane
16. Regulation of cartilage and bone differentiation by bone morphogenetic proteins
17. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin
18. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression
19. Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-beta superfamily: Selective effects of the bone morphogenetic proteins
20. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
21. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture
22. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes
23. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures
24. Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker
25. Cartilage reconstruction in head and neck surgery: Comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage
26. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction
27. A simple and very efficient method for generating cDNA libraries
28. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis
29. Inexpensive computer analysis of cell and tissue stainings
30. Cartilage destruction and bone erosion in arthritis: The role of tumour necrosis factor alpha
31. The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients
32. The Bristol 'OA500 study': Progression and impact of the disease after 8 years
33. Diability and handicap in rheumatoid arthritis and ankylosing spondylitis: Results from the German rheumatological database
34. Petulant cellular acts: Destroying the ECM rather than creating it
35. Mechanisms involved in cartilage proteoglycan catabolism
36. Effects of human recombinant interleukin-1beta on canine articular chondrocytes in three-dimensional culture
37. Effects of shear stress on articular chondrocyte metabolism
38. Changes in type of collagen synthesized as clones of chick chondrocytes grow and eventually lose division capacity
39. Expression of collagen type I, II and III in loose body of osteoarthritis
40. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation
41. Tissue engineering by cell transplantation using degradable polymer substrates
42. Tissue-engineered morphogenesis of cartilage and bone by means of cell transplantation using synthetic biodegradable polymer matrices
43. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels
44. BMP/GDF-signalling interactions during synovial joint development
45. Tissue engineering: Artificial tissue replacement containing vital components
46. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage
47. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints
48. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: Potential utility in gene therapy for osteochondral repair
49. BMPs are required at two steps of limb chondrogenesis: Formation of prechondrogenic condensations and their differentiation into chondrocytes
50. Analysis of cartilage maturation using micromass cultures of primary chondrocytes
51. BMP-5 deficiency alters chondrocytic activity in the mouse proximal tibial growth plate
52. Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments
53. Growth factor responsiveness of human articular chondrocytes: Distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts
54. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint
55. Bone morphogenetic protein-induced muscle- and synovium-derived cartilage differentiation in vitro
56. Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in ossification of the ligamentum flavum